Context

• India’s trade relations with the United States have repeatedly faced tariff tensions, raising concerns about their impact on exports, manufacturing and innovation.
• Recent tariff concessions provided relief to Indian exporters, with pharmaceuticals and several electronics products remaining exempt.
• However, the larger concern is whether high U.S. tariffs are weakening India’s research and innovation capacity.
• The evidence suggests otherwise. The deeper problem is that India’s tariff-exposed manufacturing sectors have historically invested very little in R&D.

The Reality: Tariffs Are Not the Main Cause of India’s Research Weakness

• The industries most affected by U.S. tariffs include organic chemicals, plastics, base metals, machinery, auto components and leather.
• Yet these sectors have traditionally maintained weak research programmes.
• Indian metals companies spend only about 0.4% of sales on R&D, compared with nearly 1.6% globally.
• Automobile and component manufacturers spend slightly above 2%, against around 5% globally, while electrical equipment firms spend less than 2%.
• Thus, India’s trade-exposed sectors and research-intensive sectors barely overlap.
• Research expenditure is concentrated mainly in pharmaceuticals and automobiles, while most other manufacturing industries conduct limited research.
• Tariffs on steel, chemicals or plastics therefore cannot significantly reduce research spending that was already minimal.
• Patent activity and R&D spending also show no clear break attributable to the tariff years. These sectors had followed a low-research trajectory well before the recent trade tensions.
• Tariffs are therefore more a symptom of strained trade relations than the root cause of India’s innovation deficit.

Where Tariffs Actually Matter?

• The tariff issue becomes more significant in sectors that combine substantial research activity with trade exposure.
• Automobiles are particularly vulnerable, while pharmaceuticals received protection under the recent agreement.
• The 25% U.S. duty on auto parts remains a concern, while metal tariffs increase input costs for engineering and component manufacturers.
• Higher costs and restricted market access could discourage firms from undertaking risky, long-term research.
• Therefore, the genuine research-related tariff risk is concentrated in automobiles, rather than across the entire Indian manufacturing economy.

The Deeper Problem: India’s Chronic R&D Deficit

• India’s research weakness predates the current tariff dispute.
• National R&D expenditure remains low compared with major competing economies, and the private sector contributes far less than firms in leading innovation-driven countries.
• Corporate spending often supports routine development and testing rather than breakthrough research.
• The comparison with companies such as Nvidia illustrates the scale of the gap: a single major technology company can spend almost as much on research as India’s entire corporate sector.
• The challenge is therefore not simply insufficient funding but also weak private-sector research capacity, limited incentives and inadequate technological ambition.

The ₹1 Lakh Crore Opportunity

• The government’s ₹1 lakh crore Research, Development and Innovation scheme seeks to provide long-term, low-cost capital for areas such as artificial intelligence, semiconductors, quantum technology and biotechnology.
• This investment is important for India’s technological ambitions.
• However, the scheme largely targets frontier and sunrise sectors, whereas many tariff-exposed industries belong to traditional manufacturing.
• Chemicals, metals, engineering and auto-component companies also need technological upgrading.
• India therefore requires an innovation strategy that connects traditional manufacturing with research and higher-value production.

Turning Trade Pressure into an Innovation Opportunity

• Tariff pressure can become a catalyst for industrial transformation. Instead of merely protecting vulnerable industries, India should encourage firms to develop differentiated, higher-value products that are difficult to substitute or undercut.
• Government incentives should favour genuine R&D over routine testing and target tariff-exposed sectors.
• Assistance to downstream engineering firms facing higher metal costs could be linked to continued research investment.
• Similarly, pharmaceuticals and automobiles deserve special attention in future trade negotiations because disruptions in these sectors could affect both exports and innovation.
• Protection without reform merely preserves low-value production. Government support should instead be conditional on measurable improvements in research and technological capability.

Measuring Research Better

• Effective innovation policy requires reliable data.
• India’s official R&D statistics are often delayed and underestimate private-sector research spending. Policymakers cannot effectively direct resources without knowing where research is occurring.
• A faster firm-level system linking R&D expenditure with exports, patents and productivity would help identify vulnerable industries and measure the effectiveness of government support.
• Better measurement would allow India to move from broad R&D spending towards targeted, evidence-based innovation policy.

Conclusion

• The U.S. tariff dispute is not the principal cause of India’s research weakness.
• The fundamental problem is structural: many export-oriented industries invest too little in R&D and remain concentrated in low-value production.
• The tariff truce offers India valuable breathing space to strengthen its innovation ecosystem. Support for traditional industries should be linked to research, technological upgrading and product differentiation, while frontier sectors should continue receiving strategic investment.
• India’s manufacturing resilience will ultimately depend not on permanently protecting existing products, but on creating superior products that compete through technology, quality and intellectual property.